drugset / Trial / NCT00199238
Efficacy of Rupatadine 5, 10 and 20 mg in Chronic Idiopathic Urticaria
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to evaluate the efficacy and safety of rupatadine for the treatment of CIU symptoms.To assess the clinical efficacy of a dose ranging of rupatadine fumarate (5mg, 10mg, and 20 mg) compared with placebo for relief of CIU symptoms.
Timeline
- Start
- 2002-10-28
- Primary completion
- 2003-11-25
- Completion
- 2004-09-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rupatadine | Small molecule | 5 mg | Oral |
| Subject | Rupatadine | Small molecule | 10 mg | Oral |
| Subject | Rupatadine | Small molecule | 20 mg | Oral |